Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 309,800 shares at $45.23 ($13.9M) on 2024-08-26, disclosed to the SEC on 2024-08-28.
Scheduled sale ($13.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.23 | 77,963 | $3.5M | 25.4% |
| 2 | $45.23 | 77,963 | $3.5M | 25.4% |
| 3 | $45.79 | 11,534 | $528K | 3.8% |
| 4 | $45.79 | 11,534 | $528K | 3.8% |
| 5 | $44.28 | 65,403 | $2.9M | 20.8% |
| 6 | $44.28 | 65,403 |
| $2.9M |
| 20.8% |
| Total | $44.87 avg | 309,800 | $13.9M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |